Compile Data Set for Download or QSAR
maximum 50k data
Found 18 Enz. Inhib. hit(s) with all data for entry = 50008396
TargetCholecystokinin receptor type A(Mus musculus)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073050((S)-1-(3-Amino-pentanoyl)-2,3-dihydro-1H-indole-2-...)
Affinity DataKi:  7nMAssay Description:Binding affinity of the compound in Cholecystokinin type A receptor binding assay (iv) in miceMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073046(CHEMBL60116 | N-(5-{(R)-2-[(R)-2-(3-Chloro-phenyl)...)
Affinity DataKi:  9nMAssay Description:Binding affinity of the compound towards human Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073048(2-[4-(2-Oxo-2,3-dihydro-benzoimidazol-1-yl)-piperi...)
Affinity DataIC50:  0.470nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in ratMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 1(RAT)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50065468(2-(4-Chloro-phenoxymethyl)-4-(3-piperidin-1-yl-pro...)
Affinity DataIC50:  1.70nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 1 in ratMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Rat 6B)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073051(CHEMBL60319 | N-[5-(3,4-Dimethoxy-phenyl)-1H-pyraz...)
Affinity DataIC50:  2.30nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in ratMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Rat 6B)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073055(2-Methyl-4-pyrrolidin-1-yl-6-[(E)-2-(3-trifluorome...)
Affinity DataIC50:  4.10nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in ratMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Rat 6B)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073047(CHEMBL291666 | N-[5-(3,4-Dimethoxy-phenyl)-1H-pyra...)
Affinity DataIC50:  8.30nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in ratMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073054(1-[4-Ethyl-1-(3-methoxymethoxy-phenyl)-cyclohexyl]...)
Affinity DataIC50:  39nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 4(RAT)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073048(2-[4-(2-Oxo-2,3-dihydro-benzoimidazol-1-yl)-piperi...)
Affinity DataIC50: >5.00E+3nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 4More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 2(RAT)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073048(2-[4-(2-Oxo-2,3-dihydro-benzoimidazol-1-yl)-piperi...)
Affinity DataIC50: >5.00E+3nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 1(RAT)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073048(2-[4-(2-Oxo-2,3-dihydro-benzoimidazol-1-yl)-piperi...)
Affinity DataIC50: >5.00E+3nMAssay Description:The compound was tested for the binding affinity against NPY1 (Neuropeptide Y receptor type 1)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073045((4-{(R)-2-[(R)-2-(3-Chloro-phenyl)-2-hydroxy-ethyl...)
Affinity DataEC50:  60nMAssay Description:Binding affinity of the compound towards human Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50070132((S)-N-(4-(2-(2-hydroxy-3-(4-hydroxyphenoxy)propyla...)
Affinity DataEC50:  6.30nMAssay Description:Binding affinity of the compound towards human Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073053((2-{2-[(R)-2-(3-Chloro-phenyl)-2-hydroxy-ethylamin...)
Affinity DataEC50:  0.0600nMAssay Description:Binding affinity of the compound towards human Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073049(6-(4-{2-[(S)-2-Hydroxy-3-(2-oxo-2,3-dihydro-1H-ben...)
Affinity DataEC50:  30nMAssay Description:Binding affinity of the compound towards human Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50070156((S)-4-(3-hexylureido)-N-(4-(2-(1-hydroxy-2-(4-hydr...)
Affinity DataEC50:  0.430nMAssay Description:Binding affinity of the compound towards human Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50072375(4-(3-Hexyl-ureido)-N-{4-[2-((R)-2-hydroxy-2-pyridi...)
Affinity DataEC50:  6.30nMAssay Description:Binding affinity of the compound towards human Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073052(5-{2-[(R)-2-(6-Amino-pyridin-3-yl)-2-hydroxy-ethyl...)
Affinity DataEC50:  300nMAssay Description:Binding affinity of the compound towards human Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed